|
Biden-Harris
Administration Requires Insurance Companies and Group Health Plans to
Cover the Cost of At-Home COVID-19 Tests, Increasing Access to Free
Tests
As part of its ongoing
efforts across many channels to expand Americans’ access to free
testing, the Biden-Harris Administration is requiring insurance
companies and group health plans to cover the cost of
over-the-counter, at-home COVID-19 tests, so people with private
health coverage can get them for free starting January 15th. The new
coverage requirement means that most consumers with private health
coverage can go online or to a pharmacy or store, buy a test, and
either get it paid for up front by their health plan, or get
reimbursed for the cost by submitting a claim to their plan. This
requirement incentivizes insurers to cover these costs up front and
ensures individuals do not need an order from their health care
provider to access these tests for free.
Beginning January 15,
2022, individuals with private health insurance coverage or covered
by a group health plan who purchase an over-the-counter COVID-19
diagnostic test authorized, cleared, or approved by the U.S. Food and
Drug Administration (FDA) will be able to have those test costs
covered by their plan or insurance. Insurance companies and health
plans are required to cover 8 free over-the-counter at-home tests per
covered individual per month. That means a family of four, all on the
same plan, would be able to get up to 32 of these tests covered by
their health plan per month. There is no limit on the number of
tests, including at-home tests, that are covered if ordered or
administered by a health care provider following an individualized
clinical assessment, including for those who may need them due to
underlying medical conditions.
“Under President Biden’s
leadership, we are requiring insurers and group health plans to make
tests free for millions of Americans. This is all part of our overall
strategy to ramp-up access to easy-to-use, at-home tests at no cost,”
said HHS Secretary Xavier Becerra. “Since we took office, we have
more than tripled the number of sites where people can get COVID-19
tests for free, and we’re also purchasing half a billion at-home,
rapid tests to send for free to Americans who need them. By requiring
private health plans to cover people’s at-home tests, we are further
expanding Americans’ ability to get tests for free when they need
them.”
Over-the-counter test
purchases will be covered in the commercial market without the need
for a health care provider’s order or individualized clinical
assessment, and without any cost-sharing requirements such as
deductibles, co-payments or coinsurance, prior authorization, or
other medical management requirements.
As part of the
requirement, the Administration is incentivizing insurers and group
health plans to set up programs that allow people to get the
over-the-counter tests directly through preferred pharmacies,
retailers or other entities with no out-of-pocket costs. Insurers and
plans would cover the costs upfront, eliminating the need for
consumers to submit a claim for reimbursement.
When plans and insurers
make tests available for upfront coverage through preferred
pharmacies or retailers, they are still required to reimburse tests
purchased by consumers outside of that network, at a rate of up to
$12 per individual test (or the cost of the test, if less than $12).
For example, if an individual has a plan that offers direct coverage
through their preferred pharmacy but that individual instead
purchases tests through an online retailer, the plan is still
required to reimburse them up to $12 per individual test. Consumers
can find out more information from their plan about how their plan or
insurer will cover over-the-counter tests.
“Testing is critically
important to help reduce the spread of COVID-19, as well as to
quickly diagnose COVID-19 so that it can be effectively treated.
Today’s action further removes financial barriers and expands access
to COVID-19 tests for millions of people,” said CMS Administrator
Chiquita Brooks-LaSure.
State Medicaid and
Children’s Health Insurance Program (CHIP) programs are currently
required to cover FDA-authorized at-home COVID-19 tests without
cost-sharing. In 2021, the Biden-Harris Administration issued
guidance explaining that State Medicaid and Children’s Health
Insurance Program (CHIP) programs must cover all types of
FDA-authorized COVID-19 tests without cost sharing under CMS’s
interpretation of the American Rescue Plan Act of 2019 (ARP).
Medicare pays for COVID-19 diagnostic tests performed by a
laboratory, such as PCR and antigen tests, with no beneficiary cost
sharing when the test is ordered by a physician, nonphysician
practitioner, pharmacist, or other authorized health care
professional. People enrolled in a Medicare Advantage plan should
check with their plan to see if their plan offers coverage and
payment for at-home over-the-counter COVID-19 tests.
This effort is in
addition to a number of actions the Biden Administration is taking to
expand access to testing for all Americans. The U.S. Department of
Health and Human Services (HHS) is providing up to 50 million free,
at-home tests to community health centers and Medicarecertified
health clinics for distribution at no cost to patients and community
members. The program is intended to ensure COVID-19 tests are made
available to populations and settings in need of testing. HHS also
has established more than 10,000 free community-based pharmacy
testing sites around the country. To respond to the Omicron surge,
HHS and FEMA are creating surge testing sites in states across the
nation.
For more information,
please see these Frequently Asked Questions,
https://www.cms.gov/files/document/11022-faqs-otc-testing-guidance.pdf
For additional details on
the requirements, visit https://www.dol.gov/sites/dolgov/files/EBSA/about-ebsa/our-activities/resource-center/faqs/aca-part-51.pdf
###
Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on Twitter @CMSgov
|
No comments:
Post a Comment